The first tumor was left breast cancer at 26 years (Stage III, IDC, ER + /PR + /HER2 − ) treated with neoadjuvant chemotherapy with anthracycline followed by taxane, then by mastectomy with axillary lymph node dissection (Ax), with residual cancer in five nodes. This evidence concerns the gene ERBB2 and cancer.